Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01284010 · ClinicalTrials.gov registry record
Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 200
- Enrollment target
NCT01284010 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 200 participants.
The verdict
NCT01284010 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is studying biomarkers in blood and bone marrow samples from patients with acute lymphoblastic leukemia.
Interventions
- GENETIC gene expression analysis
- GENETIC microarray analysis
- GENETIC mutation analysis
- GENETIC DNA analysis
- GENETIC fluorescence in situ hybridization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-02 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01284010
The ClinicalTrials.gov registry entry for NCT01284010 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT01284010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01284010 about?
NCT01284010 is a clinical study titled "Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia". RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is studying biomarkers in blood and bone marrow samples from patients ...
What is the current status of trial NCT01284010?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2011-02. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01284010?
The interventions under investigation include: gene expression analysis (GENETIC), microarray analysis (GENETIC), mutation analysis (GENETIC), DNA analysis (GENETIC), fluorescence in situ hybridization (GENETIC).
Who is sponsoring clinical trial NCT01284010?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.